Ukungcola kwe-Amino Acid esetyenziselwe ukwenziwa kweproteni
Iinkcukacha zemveliso
| NO | Iimveliso | I-HAY | Isalathiso seXabiso eliPhambili | |||
| Ubunyulu | UMax. ukungcola | Iyonke intsalela ye-solvent | Ukufuma | |||
| 1 | I-FMOC-β -a-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | I-Fmoc-D-AA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | I-FMOC-β-d-d-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | I-FMOC-ARG (PBF) -Aarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | I-FMOC-β-Arg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | I-FMOC-D-ARG (PBF) -D-ARG (PBF) -UOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | I-FMOC--AAA-D-ARG (PBF) -UOh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | I-Fmoc-homoarg (PBF) -Umomoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | I-FMOC-β-homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | I-FMOC-AST (TRT) -as (i-TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | I-FMOC-β-asn asn (TRT) -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | I-FMOC-ASP (OTBHU) -ASP (OTB | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | I-FMOC--AA-AMP (OTBU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | I-FMOC-CYS (i-TRT) -cys (i-TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | I-FMOC--a-cys (i-TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | I-FMOC-CYS (i-ACM) -cys (i-ACM) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | I-FMOC-β-cys (i-ACM) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | I-FMOC-gln (TRT) -GLN (TRT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | I-FMOC-β-gln (TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | I-FMOC-glu (otbu) -Glu (oTB) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | I-FMOC-β-glu (otbu) -h2o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | I-FMOC-β-gly-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | I-Fmoc-yakhe (i-TRT) -his (i-TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | I-FMOC-β -a -a-yakhe (i-TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | I-FMOC-ILE-ILE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | I-FMOC--Ala-Ile-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmoc-leu-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | I-FMOC--leu-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | I-FMOC-D-Leu-Leu-Leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | I-FMOC--ala-d-leu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | I-Fmoc-lys | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | I-FMOC-β-lys (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | I-FMOC-lys (Alloc) -Kals (Alloc) -Ah | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | I-FMOC-β-lys (i-alloc) -Ah | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | I-FMOC-timed-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | I-FMOC-β-qued-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | I-Fmoc-Orn (BoC) -Oor (BoC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | I-FMOC-β-ala-orn (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | I-FMOC-PHI-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | I-FMOC-β-phe-phe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | I-FMOC-D-PHE-D-Dhe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | I-FMOC--AAA-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | I-FMOC-Pro-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | I-FMOC-β-pro-pro-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | I-FMOC-SUR (TBU) -USET (TBU) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | I-FMOC-β-ala-ser (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | I-FMOC-Ser (i-TRT) -Selser (TRT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | I-Fmoc--Ala-Ser (TRT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | I-FMOC-TARY (TBU) -TR (TBU) -Uh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | I-FMOC-β-thanda (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | I-FMOC-TRP (BoC) -TRP (BoC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | I-FMOC-β-trp (BoC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | I-FMOC-D-TRP (BOC) -D-trp (BoC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | I-FMOC--A-D-D-trp (BoC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | I-FMOC-Tyr (TBU) -tyr (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | I-FMOC-β-tyr (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | I-FMOC-D-tyr (et) -d-tyr (et)-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | I-FMOC-β-d-d-tyr (et)-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | I-Fmoc-tyr (mna) -tyr (mna) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | I-FMOC-β-tyr (mna) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | I-FMOC-Val-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | I-FMOC-β-val-vali-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | I-FMOC-D-CIT-D-D-Q-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | I-FMOC-β-β-d-quit-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | I-FMOC-β-dab-dab-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | I-FMOC- (3- (2-Naphthyl) -D-Ala) 2-Owu | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | I-FMOC--a-3- (2-naphthyl) -D-AO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | I-FMOC- (3- (3-pyridlinyl) -D-ALA I-2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | I-FMOC--a-3- (3-pyridnl) -D-AO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | I-FMOC- (4-chloro-d-phe) 2-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | I-FMOC--A-4-CHLO-D-DHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | I-Fmoc- (D-4aph (Tbcbm) 2-Owu | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | I-FMOC--A-D-D-4aph (TBCBM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | I-FMOC-APH (L-HOR) -Aph (I-L-HOH) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | I-FMOC-β-aph (i-L-ro) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | I-FMOC-lys (i-IPR, i-BoC) -i-IPRE, BOC) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | I-FMOC-β-lys (i-i-i-i i-ic) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | I-FMOC-β-aeea-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | I-FMOC-AIB-AIB | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | I-FMOC--AALI-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | I-FMOC-ARG-OH | I-91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | I-H-ARG (PBF) -oh | Ngo-200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | I-FMOC-D-Arg-oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | I-HD-ARG (PBF) -oh | Ngo-200116-81-0-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | I-Fmoc-homoarg-oh.hcl | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | I-H-homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | I-Fmoc-D-homoarg-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | I-HD-homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | I-FMOC-ASN-OH | I-71989-16-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | I-H-AST (TRT) -OOH | 132388-55-0-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | I-FMOC-ASP-oh | I-119062-05-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | I-H-ASP (OTBU) -oh | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | I-FMOC-CYS-OH | 135248-89-4-4-4-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | I-H-CYS (i-TRT) -Oh | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | I-H-CYS (i-ACM) -Oh.HCL | 28798-28-9-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | I-FMOC-gln-oh | I-71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | I-H-GLN (TRT) -OOH | I-102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | I-FMOC-glu-oh | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | I-H-GLu (otbu) -h2o | 2419-56-9-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-100 | I-Fmoc-yakhe-oh | I-116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-101 | H-yakhe (i-TRT) -oh | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-102 | Boc-yakhe-oh | 17791-52-5-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-103 | I-Fmoc-lys-oh | I-105047-45-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-104 | I-H-lys (BoC) -oh | I-2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-105 | I-H-lys (Alloc) -Ah | I-6298/3/9/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-106 | I-FMOC-ORN-OH.HCL | Ngo-201046-573 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-107 | I-H-ORN (BOC) -OOH | 13650-49-20-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-108 | I-FMOC-Ser-oh | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-109 | I-H-Ser (i-TBU) -oh | Ngo-18822-58-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-110 | I-H-Ser (TRT) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | I-FMOC-te-oh.h2o | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-Thring (tbu) -oh | 4378-13-6-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-113 | I-FMOC-TRP-oh | 35737-6-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | I-H-TRP (BoC) -oh | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | I-FMOC-D-trp-oh | I-86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | I-HD-trp (boc) -oh | Ngo-201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | I-Fmoc-tyr-oh | I-92954-90-0-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | I-H-tyr (TBU) -oh | 18822-599-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | I-Fmoc-D-tyr-oh | I-112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| I-120 | I-HD-tyr (et)-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | I-H-tyr (mna)-mnah.hcl | I-6742344-43 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | I-FMOC-D-4aph (i-CBM) -oh | 324017-22-33 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | I-HD-4aph (TBCBM) -OOH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | I-FMOC-lys (iPRE) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | I-H-lys (i-IPRE, ye-BOC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Malunga
Imbuyekezo
IGentolex ibonelela ngeemveliso ezisemgangathweni, ukuba nayiphi na imveliso imveliso iphakanyiselwa ngumthengi ngaphakathi kwexesha elifanelekileyo malunga nobungqina obaneleyo, siya kubonelela uhlalutyo oluyimfuneko kunye nokuvavanywa kwembuyekezo.
Imveliso
Amandla eemveliso zamayeza afikelela kwiBanga leTons, amandla eemveliso zekheminyi lemichiza afikelela kwiBanga le-100TTAS +, iBakala lixhotyiswe kakuhle ekusebenzeni abathengi kwihlabathi liphela.
Uphando nophuhliso
Rhoqo ngonyaka, kukho iSicwangciso semigaqo ye-R & D ukuphuhlisa iimveliso ezahlukeneyo, xa kujoliswe kuzo, ilungu ngalinye leqela liya kufuneka liqhubeke noxanduva lwe-KPI kunye nomgaqo-nkqubo wenkuthazo.
